item management s discussion and analysis of financial condition and results of operations the information contained in this section should be read in conjunction with company s consolidated financial statements and notes thereto 
forward looking statements the information contained herein contains certain forward looking statements 
these statements include the plans and objectives of management for future operations and financial objectives  portfolio growth and availability of funds 
these forward looking statements are subject to the inherent uncertainties in predicting future results and conditions 
certain factors that could cause actual results and conditions to differ materially from those projected in these forward looking statements are set forth herein 
see risk factors contained in item business 
other factors that could cause actual results to differ materially include the uncertainties of economic  competitive and market conditions  and future business decisions  all of which are difficult or impossible to predict accurately and many of which are beyond the control of the company 
although the company believes that the assumptions underlying the forward looking statements included herein are reasonable  any of the assumptions could be inaccurate and therefore there can be no assurance that the forward looking statements included or incorporated by reference herein will prove to be accurate 
therefore  the inclusion of such information should not be regarded as a representation by the company or any other person that the objectives and plans of the company will be achieved 
statement of operations the company accounts for its operations under accounting principles generally accepted in the united states for investment companies 
on this basis  the principal measure of its financial performance is captioned net increase decrease in net assets resulting from operations  which is the sum of three elements 
the first element is net operating income loss  which is the difference between the company s income from interest  dividends  fees and other income and its operating expenses  net of applicable income tax benefit expense 
the second element is net realized gain loss on investments  which is the difference between the proceeds received from dispositions of portfolio securities and their stated cost  net of applicable income tax benefit expense 
these two elements are combined in the company s financial statements and reported as net realized income loss 
the third element  net decrease increase in unrealized appreciation on investments  is the net change in the fair value of the company s investment portfolio 
net realized gain loss on investments and net decrease increase in unrealized appreciation on investments are directly related 
when a security is sold to realize a gain loss  net unrealized appreciation decreases increases and net realized gain increases decreases 
financial condition the company s total assets decreased by  or percent to  and its net assets decreased by  or percent to  at december   versus  and  at december  net asset value per share nav was at december   versus at december  nav was reduced by in and in by the cash dividends paid by the company 
among the significant increases in values of the company s holdings during including holdings which the company sold during were  in alliance pharmaceutical corp 
including realized gain  in which the company sold its position during   in nanophase technologies   in genomica  as a result of its initial public offering genomica corporation commenced trading on nasdaq on september   and  in essential 
com which acquired sundial marketplace 
among the significant decreases in values of the company s holdings during were  in sciquest 
com net of the gain realized on the sale of its original position and including the unrealized loss on the shares purchased during the year   in kana communications  which acquired silknet software  net of the gain realized on the sale of  shares  and  in questech corporation 
net assets were further affected by a decrease in the company s profit sharing plan accrual of  as a result of a net decrease in unrealized appreciation for the year  and an increase in the company s total tax liability of  reflecting the shareholder tax payable on long term gains realized on the sales of shares of sciquest 
com  alliance pharmaceutical corp 
and kana communications 
the company plans to retain the proceeds of these gains rather than distribute the funds to shareholders as a cash dividend 
accordingly  the company declared an undistributed capital gain dividend 
see recent developments sub chapter m status 
the company s shares outstanding as of december  were  versus  at december  on october   the company announced that the board of directors had authorized a repurchase program in the open market of up to million of the company s stock 
through december   the company had purchased a total of  shares at approximately per share for a total of  the company s financial condition is dependent on the success of its investments 
the company has invested a substantial portion of its assets in private development stage or start up companies 
these private businesses tend to be thinly capitalized  unproven  small companies that lack management depth  are dependent on new  commercially unproven technologies and have no history of operations 
at december    or percent of the company s total assets consisted of investments at fair value in publicly traded securities three of which were private businesses at the time the company made the investments  of which net unrealized appreciation was   or percent of the company s total assets consisted of non publicly traded securities at fair value in private businesses and publicly traded companies  of which net unrealized appreciation was  at december    or percent of the company s total assets consisted of investments at fair value in publicly traded securities that were private businesses at the time the company made the investments  of which net unrealized appreciation was   or percent of the company s total assets consisted of non publicly traded securities at fair value in private businesses and publicly traded companies  of which net unrealized appreciation was  the decrease in the value of publicly traded securities of  or percent from  in to  in was primarily owing to the sales and decrease in value of shares of sciquest 
com of  and the sales and the decrease in the value of shares of kana communications of  these decreases were partially offset by the increase in value of  and reclassification of genomica corporation to a publicly traded security as a result of its initial public offering genomica corporation commenced trading on nasdaq on september   the company s position in genomica is subject to a lock up agreement which expires on march   and the increase in the value of nanophase technologies of  the changes in the value of sciquest 
com  kana communications and nanophase technologies occurred during a period of extreme volatility of publicly traded  small capitalization  high technology stocks 
the volatility of the overall market may continue to have a significant impact on the performance of the company s investments 
in addition  the company may be subject to lock up agreements which may limit the company s ability to sell investments 
the value of the company s investments will vary on a quarterly basis 
see risk factors 
the decrease in the value of the non publicly traded securities of  or percent from  at december  to  at december  was primarily owing to the reclassification of genomica corporation  valued at  at december   to a publicly traded security as a result of its initial public offering  the sale of the company s position in alliance pharmaceutical valued at  at december   the liquidation of adaptive web technologies valued at  at december   and the decrease in the valuation of the company s investment in questech corporation of  net of the company s additional  investment in that company 
these decreases were offset by investments in neurometrix  inc of  in sundial marketplace of  as well as an increase in its value of  as a result of its june  tax free acquisition by essential 
com  experion systems formerly named mypersonaladvocate 
com  inc of  informio  inc of  formerly named ipacer corporation  and harris newco  inc of  a summary of the company s investment portfolio is as follows december  december  investments  at cost   unrealized appreciation   investments  at fair value   the accumulated unrealized appreciation on investments net of deferred taxes is  at december   versus  at december  following an initial investment in a private company  the company may make additional investments in such investee in order to increase its ownership percentage  exercise warrants  options or convertible securities that were acquired in the original or subsequent financing  preserve the company s proportionate ownership in a subsequent financing  or attempt to preserve or enhance the value of the company s investment 
there can be no assurance that the company will make follow on investments or have sufficient funds to make additional investments 
the company has the discretion to make follow on investments as it determines  subject to the availability of capital resources 
the failure to make such follow on investments may  in certain circumstances  jeopardize the continued viability of the investee company and the company s initial investment or may result in a missed opportunity for the company to increase its participation in a successful operation 
even if the company has sufficient capital to make a desired follow on investment  it may elect not to make a follow on investment either because it does not want to increase its concentration of risk  because it prefers other opportunities  or because it is inhibited by compliance with bdc or ric requirements  even though the follow on investment opportunity appears attractive 
the following table is a summary of the cash investments and loans made by the company in its private placement portfolio during the year ended december  new investments amount experion systems  inc  informio  inc  harris newco  inc  additional investments genomica corporation  sundial marketplace corporation  formerly named mypersonaladvocate 
com  inc formerly named ipacer corporation 
acquired by essential 
com  inc loans neurometrix  inc  questech corporation  sundial marketplace corporation  exercise of warrants held alliance pharmaceutical corp 
 total  converted to equity and acquired by essential 
com  inc converted to equity as part of a recently completed million equity financing of neurometrix  inc converted to equity as part of a million equity financing of questech corporation 
results of operations investment income and expenses the company had a net operating income loss of  in   in and  in the net operating income for reflected a decrease in the employee profit sharing accrual that resulted in a credit to expenses of 
the net operating losses in and reflect accruals for employee profit sharing of  and  respectively 
when unrealized appreciation as of a certain period subsequently decreases the profit sharing accrual will be decreased accordingly  resulting in a credit to expenses  thereby reducing expenses for such subsequent year by that amount 
the company s primary investment objective is to achieve long term capital appreciation rather than current income from its investments 
therefore  a significant portion of the investment portfolio is structured to attempt to enhance the potential for capital appreciation and provides little or no current yield in the form of dividends or interest 
the company does earn interest income from fixed income securities  including us government obligations 
the amount of interest income earned varies based upon the average balance of the company s fixed income portfolio and the average yield on this portfolio 
the company also received or accrued net after tax distributions from its investment in phz capital partners  lp in of  in of  and in of  the company does not regard distributions from phz as predictable 
the company had total investment income of  in   in and  in the company had interest income from fixed income securities of  in   in and  in the increase from to of  or percent was owing to the company having additional funds to invest as the result of the sale of the sciquest 
com and alliance pharmaceutical securities 
the decrease from to of  or percent was primarily owing to a decline in the balance of the company s fixed income portfolio during and as a result of the payment of dividends  additional investments and operating expenses 
the company had interest income from affiliated companies of  in   in and  in the increase from to of  or percent and the decrease from to of  or percent is owing to the change in amount of outstanding loans during the periods 
the amount of outstanding loans to investee companies varies 
typically  loans made to investee companies are bridge loans and are converted into equity at the next financing 
the company had other income of  in   in and  in the other income in represents rental income for subleasing office space  in december  the company began subleasing office space to an unaffiliated party 
the other income in reflected income from an affiliated company  biosupplynet  to reimburse the company for consulting fees previously paid and expensed by the company on behalf of biosupplynet 
operating expenses were  in   in and  in the operating expenses for the year ended december  reflect a reversal of a prior expense accrual of  in the employee profit sharing plan  as a result of a net decrease in unrealized appreciation for the current year  resulting in a credit to expenses 
salaries and benefits increased  or percent primarily as a result of the company s contribution to the supplemental executive retirement plan or serp 
see note of notes to consolidated financial statements contained in 
